Decoding Hypoxia‐Induced Metabolomic Changes in Breast Cancer EVs and Their Functional Effects on Cancer Cells
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Ashish Sahu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Palaj, Gandhinagar, Gujarat, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Metabolomics, Extracellular Vesicles. Die Arbeit nennt 62 Literaturangaben. Gefördert von: This study was supported by ANRF (formerly SERB), India grant no. EEQ/2022/000309 and Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, New….
Abstract (Originalsprache)
This study utilized an untargeted metabolomic approach using LC‐MS/MS to analyze the metabolic alterations in extracellular vesicles (EVs) secreted by breast cancer cells under hypoxic conditions. EVs were isolated using an established ultracentrifugation protocol, and their homogeneity was assessed through TEM, SEM, NTA, and immunoblotting. Metabolic extracts from hypoxic EVs were found to enhance breast cancer cell migration, invasion, and epithelial–mesenchymal transition (EMT), underscoring their role in tumor progression. Metabolomic analysis identified over 400 annotated metabolites, with univariate statistical analysis ( p < 0.05, Log 2 FC > 0.58/< −0.58) revealing 48 significantly altered metabolites in MDA‐MB‐231‐ and MCF‐7‐derived EVs, respectively, indicating substantial metabolic reprogramming under hypoxia. Integrated univariate and multivariate analyses ( p < 0.05, Log 2 FC > 0.58/< −0.58, VIP > 1) identified key upregulated metabolites, including riboflavin, 5,6‐epoxy‐8,11,14‐eicosatrienoic acid, and furandicarboxylic acid, in hypoxic EVs from both cell lines. Additionally, N‐acetyl‐ l ‐methionine, 2,6‐diamino‐4‐hydroxy‐5‐N‐methylformamidopyrimidine, and 5,10‐methenyltetrahydrofolic acid were identified as critical metabolites potentially influencing cell proliferation, DNA damage, and epigenetic regulation. Metabolic pathway analysis highlighted heightened activity in aromatic amino acid and riboflavin metabolism. These findings reveal significant metabolic alterations in hypoxic EVs, providing insights into their potential role in driving tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Palaj, Gandhinagar, Gujarat, India.
- Department of Natural Products, National Institute of Pharmaceutical Education and Research, Ahmedabad, Palaj, Gandhinagar, Gujarat, India.
ORCID-Profile: Ashish Sahu, Vaidehi Bhavsar, Ravindra Taware
Förderung
- This study was supported by ANRF (formerly SERB), India grant no. EEQ/2022/000309 and Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, New…
Zitieren
APA
Sahu, A., Bhavsar, V., & Taware, R. (2025). Decoding Hypoxia‐Induced Metabolomic Changes in Breast Cancer EVs and Their Functional Effects on Cancer Cells. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70139
Vancouver
Sahu A, Bhavsar V, Taware R. Decoding Hypoxia‐Induced Metabolomic Changes in Breast Cancer EVs and Their Functional Effects on Cancer Cells. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70139
BibTeX
@article{Sahu2025,
author = {Sahu, Ashish and Bhavsar, Vaidehi and Taware, Ravindra},
title = {Decoding Hypoxia‐Induced Metabolomic Changes in Breast Cancer EVs and Their Functional Effects on Cancer Cells},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70139}
}
EUVIMED